Analyst firms · Barclays · RDNT

Barclays RDNT price target and rating history

RadNet Inc. (RDNT) · Health Care

Barclays rates RadNet Inc. (RDNT) Overweight with a $79 price target, as of its latest action on Sep 6, 2024. It has published 3 rating actions on RDNT since August 2021, including 1 upgrade and 0 downgrades.

Current rating
Overweight
Price target
$79
Median target, all firms
Too few
Actions on RDNT
3

Barclays price target on RDNT

$79$59$3920222023202420252026
Barclays price target on RDNT, each point a stated target, August 2021 to September 2024.

Every Barclays rating on RDNT

Questions about Barclays and RDNT

What is Barclays's price target for RDNT?
Barclays's latest stated price target for RadNet Inc. (RDNT) is $79, from its action on Sep 6, 2024.
What is Barclays's rating on RDNT?
Barclays rates RDNT Overweight, a bullish rating, as of Sep 6, 2024.
When did Barclays last change its view on RDNT?
On Sep 6, 2024, Barclays upgrades to Overweight from Equal Weight, price target $57 to $79.

More RDNT rating histories

All Barclays ratingsRDNT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.